Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam, Alcon, and More

Premium

Title: siRNA Compositions and Methods for Potently Inhibiting Viral Infection

Patent Number: 8,664,188

Filed: Dec. 11, 2009

Lead Inventor: Bojian Zheng, Xiangxue Group


Title: RNA Interference in Skin Indications

Patent Number: 8,664,189

Filed: Sept. 22, 2009

Lead Inventor: Anastasia Khvorova, RXi Pharmaceuticals


Title: Mutator Activity Induced by microRNA-155 Links Inflammation and Cancer

Patent Number: 8,664,192

Filed: March 7, 2012

Inventor: Carlo Croce, Ohio State University (Microlin Bio)


Title: Compositions and Methods for Inhibiting Expression of Factor VII Gene

Patent Number: 8,664,193

Filed: Sept. 14, 2012

Lead Inventor: Antonin de Fourgerolles, Alnylam Pharmaceuticals


Title: Interfering RNA Delivery Systems and Uses Thereof

Patent Number: 8,664,375

Filed: Dec. 14, 2010

Inventor: Jon Chatterton, Alcon


Title: Use of Two microRNA [Molecules] in Lung Cancer Prognosis and Medicine Preparation

Patent Number: 8,664,191

Filed: July 9, 2009

Lead Inventor: Qimin Zhan, Chinese Academy of Medical Services